Why do two people with the same cancer diagnosis—the same stage, the same cell type, and the same clinical profile—often have ...

Researchers at The University of Texas MD Anderson Cancer Center have characterized cancer cell-specific features in the ...

Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have ...

Genetic material shed by tumors can be detected in the bloodstream three years prior to cancer diagnosis, according to a study led by investigators at Johns Hopkins University. The study, partly ...

Medications are designed to treat diseased tissues while sparing healthy ones, often by attaching the drug to something that helps guide it directly to its target. But drugs also need time to work, ...

Scientists long ago identified their target: a smooth-surfaced protein inside cells, called KRAS, that is altered in certain ...

Scientists are creating a glioblastoma 'tumor on a chip'—a tiny living system capable of mimicking the key features of the ...

Researchers have uncovered an unexpected weakness in pancreatic cancer involving damaged mitochondria and a powerful ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist antibodies. On paper, they looked like a breakthrough. In mice and other lab ...

Former Sen. Ben Sasse of Nebraska reveals an experimental cancer drug helped shrink his tumors by 76% after a stage 4 metastatic pancreatic cancer diagnosis.

An artificial intelligence model from the Mayo Clinic detected early signs of possible pancreatic cancer on scans up to two ...

Matthew Herper covers medical innovation — both its promise and its perils. The biotech firm Nuvalent said Tuesday that new data indicate its targeted drug zidesamtinib could help patients with a rare ...